Similar articles for PMID: 22050263

Year	Number of Results
2002	1
2003	3
2004	4
2005	3
2006	5
2007	2
2008	5
2009	2
2010	1
2011	6
2012	3
2013	2
2014	3
2015	1
2016	2
2017	2
2019	1
2020	2
2021	1
2024	0

1

Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities.

Palomo V, Soteras I, Perez DI, Perez C, Gil C, Campillo NE, Martinez A. Palomo V, et al. J Med Chem. 2011 Dec 22;54(24):8461-70. doi: 10.1021/jm200996g. Epub 2011 Nov 16. J Med Chem. 2011. PMID: 22050263

2

Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic.

Medina M, Castro A. Medina M, et al. Curr Opin Drug Discov Devel. 2008 Jul;11(4):533-43. Curr Opin Drug Discov Devel. 2008. PMID: 18600569 Review.

3

Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.

Zhang P, Li S, Gao Y, Lu W, Huang K, Ye D, Li X, Chu Y. Zhang P, et al. Bioorg Med Chem Lett. 2014 Dec 15;24(24):5639-5643. doi: 10.1016/j.bmcl.2014.10.078. Epub 2014 Oct 30. Bioorg Med Chem Lett. 2014. PMID: 25467150

4

Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.

Comess KM, Sun C, Abad-Zapatero C, Goedken ER, Gum RJ, Borhani DW, Argiriadi M, Groebe DR, Jia Y, Clampit JE, Haasch DL, Smith HT, Wang S, Song D, Coen ML, Cloutier TE, Tang H, Cheng X, Quinn C, Liu B, Xin Z, Liu G, Fry EH, Stoll V, Ng TI, Banach D, Marcotte D, Burns DJ, Calderwood DJ, Hajduk PJ. Comess KM, et al. ACS Chem Biol. 2011 Mar 18;6(3):234-44. doi: 10.1021/cb1002619. Epub 2011 Jan 20. ACS Chem Biol. 2011. PMID: 21090814

5

Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.

Perez DI, Palomo V, Pérez C, Gil C, Dans PD, Luque FJ, Conde S, Martínez A. Perez DI, et al. J Med Chem. 2011 Jun 23;54(12):4042-56. doi: 10.1021/jm1016279. Epub 2011 May 17. J Med Chem. 2011. PMID: 21500862

6

SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.

Martinez A, Alonso M, Castro A, Dorronsoro I, Gelpí JL, Luque FJ, Pérez C, Moreno FJ. Martinez A, et al. J Med Chem. 2005 Nov 17;48(23):7103-12. doi: 10.1021/jm040895g. J Med Chem. 2005. PMID: 16279768

7

Investigation of potential glycogen synthase kinase 3 inhibitors using pharmacophore mapping and virtual screening.

Dessalew N, Bharatam PV. Dessalew N, et al. Chem Biol Drug Des. 2006 Sep;68(3):154-65. doi: 10.1111/j.1747-0285.2006.00430.x. Chem Biol Drug Des. 2006. PMID: 17062013

8

Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.

Polychronopoulos P, Magiatis P, Skaltsounis AL, Myrianthopoulos V, Mikros E, Tarricone A, Musacchio A, Roe SM, Pearl L, Leost M, Greengard P, Meijer L. Polychronopoulos P, et al. J Med Chem. 2004 Feb 12;47(4):935-46. doi: 10.1021/jm031016d. J Med Chem. 2004. PMID: 14761195

9

Generation and evaluation of a homology model of PfGSK-3.

Kruggel S, Lemcke T. Kruggel S, et al. Arch Pharm (Weinheim). 2009 Jun;342(6):327-32. doi: 10.1002/ardp.200800158. Arch Pharm (Weinheim). 2009. PMID: 19475596

10

5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3.

Palomo V, Perez DI, Perez C, Morales-Garcia JA, Soteras I, Alonso-Gil S, Encinas A, Castro A, Campillo NE, Perez-Castillo A, Gil C, Martinez A. Palomo V, et al. J Med Chem. 2012 Feb 23;55(4):1645-61. doi: 10.1021/jm201463v. Epub 2012 Feb 3. J Med Chem. 2012. PMID: 22257026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year